Dr. Stanley Goldstein, MD

Dr. Goldstein practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Goldstein's NPI, 1548343304, was assigned on October 23, 2006. Dr. Goldstein graduated from New York Medical College in 1975. Dr. Goldstein holds New York license 128390.

Dr. Goldstein's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Goldstein's primary practice is New Hyde Park Endoscopy in Lake Success, New York. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Goldstein to 3 more physician offices, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 5 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Goldstein is licensed in New York.

CMS data shows 5,315 Medicare services from Dr. Goldstein across 12 procedure codes in 2024, for 233 Medicare patients. Medicare paid $82,165 for them. Every service was in an office.

CMS counts 233 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 25, with 54% women.

In 2024, Dr. Goldstein wrote 703 Medicare Part D claims for 172 patients. 64% of them were for generic drugs. CMS names the drug for 543 of them, across 21 drugs with 11 or more claims each, at $231,583 in total drug cost. In 2023, CMS named 618 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Goldstein for performance year 2024, reported through an alternative payment model (APM). Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Goldstein, published from 2016 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Brain, Mice, Inbred BALB C and Homeodomain Proteins. Dr. Goldstein has published most often in bioRxiv. Dr. Goldstein's most frequent co-authors are Lauren Brown, CMA, Alice Chen Fan, MD and Gary A. Peltz, MD.

CMS Open Payments shows 1,851 general payments to Dr. Goldstein from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Genentech, Inc. paid the most, $267,623. It also lists 8 research payments totaling $12,165 from 2016 to 2024.

Dr. Goldstein graduated from New York Medical College in 1975.